Skip to content

Kori-tofu Proteins and Blood Glucose Response

Kori-tofu Proteins and Blood Glucose Response

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04233281
Acronym
KoPro
Enrollment
24
Registered
2020-01-18
Start date
2020-01-06
Completion date
2020-03-01
Last updated
2020-03-26

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Glucose Intolerance

Keywords

Kori tofu, Glucose response, Pre-diabetics

Brief summary

The study is a randomized, cross-over, double blind, controlled trial in which study participants will visit the research facility on two occasions under fasting conditions with a minimum of 1 week between visits. During each visit, participants will receive a carbohydrate rich test-meal with Kori-tofu (protein) or whey protein. The two meals will be given in randomized order and blood will be collected via a catheter before and up to 3 hours after consumption of the test-meal. Study participants will also wear continuous glucose meters during the trial. They will receive a standardized evening meal prior to each study day and are asked not to drink alcohol or perform heavy exercise the day before. After each test day participants are offered a meal.

Detailed description

There are several types of tofu, an example of a specific type of tofu is called Kori-tofu. Kori-tofu literally means frozen tofu. The production process of Kori-tofu leads to the formation of a higher high molecular weight fraction (HMF) content of the soy proteins. Several clinical studies describe the effects of Kofi-tofu on health. In this study, the aim is to investigate whether Kori-tofu protein affects postprandial blood glucose concentrations in participants with an impaired glucose tolerance. The primary objective is to investigate whether Kori-tofu protein affects postprandial blood glucose concentrations, when administered as a part of an ordinary high carbohydrate meal. The secondary objective is to investigate whether Kori-tofu protein affects postprandial insulin concentrations. The study is a randomized, cross-over, double blind, controlled trial in which study participants will visit the research facility on two occasions under fasting conditions. Subjects will receive two different carbohydrate-rich meals, either with added Kori-tofu or whey protein, with a washout period of one week. Blood will be collected via a catheter before and up-to 3 hours after consumption of the test-meal.

Interventions

OTHERKori tofu

16.5 gram Kori-tofu mixed in a high carbohydrate test meal

OTHERWhey protein

high carbohydrate test meal with whey protein, matched in macronutrient content

Sponsors

Asahimatsu Support BV
CollaboratorUNKNOWN
Wageningen University and Research
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
DOUBLE (Subject, Investigator)

Eligibility

Sex/Gender
ALL
Age
50 Years to 75 Years
Healthy volunteers
No

Inclusion criteria

* BMI \>25 kg/m2 * Having veins suitable for blood sampling via a catheter * Having one or more of the following criteria: * HbA1c\> 6% * fasting glucose \>6.1mmol/L * two-hour glucose levels \>7.8 mmol/L on the 75-g oral glucose tolerance test.

Exclusion criteria

* History of gastro-intestinal surgery or having (serious) gastro-intestinal complaints * History of liver dysfunction (cirrhosis, hepatitis) or liver surgery * Kidney dysfunction (self-reported) * Use of medication/supplements that may influence the study results, such as med-icines known to interfere with glucose homeostasis (judged by our study doctor) * Anaemia (Hb values \<7.5 for women and \<8.5 for men) * Reported slimming, medically prescribed or other extreme diets * Reported weight loss or weight gain of \> 5 kg in the month prior to pre-study screening * Not willing to give up blood donation during the study * Current smokers * Alcohol intake ≥4 glasses of alcoholic beverages per day * Abuse of illicit drugs * Food allergies for products that we use in the study * Participation in another clinical trial at the same time * Being an employee of the Food, Health & Consumer Research group of Wageningen Food & Biobased Research.

Design outcomes

Primary

MeasureTime frameDescription
change in blood glucose levels after a carbohydrate rich mealblood samples will be taken before and up to 3 hours after test meal consumptionpostprandial test, determine glucose levels in blood samples collected before and after the test meal

Secondary

MeasureTime frameDescription
change in blood insulin levels after a carbohydrate rich mealblood samples will be taken before and up to 3 hours after teast meal consumptionpostprandial test, determine insulin levels in blood samples collected before and after the test meal
change in postprandial glucose concentrations after food intake1.5 week in total to cover both test days and 3-4 days prior to the test daymeasured by a continuous glucose monitoring device

Countries

Netherlands

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026